EP Patent

EP3817777B1 — Freeze-dried formulation for gas-filled microvesicles

Assigned to Bracco Suisse SA · Expires 2024-11-20 · 1y expired

What this patent protects

Patent listed against sulfur-hexafluoride-lipid-type-a-microspheres.

Drugs covered by this patent

sulfur-hexafluoride-lipid-type-a-microspheres (Sulfur hexafluoride lipid-type A microspheres) · Children's Hospital of Philadelphia

Patent Metadata

Patent number: EP3817777B1
Jurisdiction: EP
Classification: —
Expires: 2024-11-20
Drug substance claim: No
Drug product claim: No
Assignee: Bracco Suisse SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.